Reviewing Spectral Medical (OTCMKTS:EDTXF) and Sintx Technologies (NASDAQ:SINT)

Spectral Medical (OTCMKTS:EDTXFGet Free Report) and Sintx Technologies (NASDAQ:SINTGet Free Report) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their profitability, analyst recommendations, valuation, institutional ownership, risk, earnings and dividends.

Analyst Recommendations

This is a summary of recent ratings and recommmendations for Spectral Medical and Sintx Technologies, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Spectral Medical 0 0 0 0 N/A
Sintx Technologies 0 1 0 0 2.00

Earnings and Valuation

This table compares Spectral Medical and Sintx Technologies’ top-line revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Spectral Medical $1.18 million 79.58 -$11.60 million ($0.04) -8.43
Sintx Technologies $2.63 million 0.08 -$8.26 million ($3.42) -0.01

Sintx Technologies has higher revenue and earnings than Spectral Medical. Spectral Medical is trading at a lower price-to-earnings ratio than Sintx Technologies, indicating that it is currently the more affordable of the two stocks.

Volatility & Risk

Spectral Medical has a beta of 0.81, suggesting that its share price is 19% less volatile than the S&P 500. Comparatively, Sintx Technologies has a beta of 1.47, suggesting that its share price is 47% more volatile than the S&P 500.


This table compares Spectral Medical and Sintx Technologies’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Spectral Medical -974.16% N/A -192.15%
Sintx Technologies -314.39% -67.12% -45.49%

Institutional & Insider Ownership

18.4% of Sintx Technologies shares are held by institutional investors. 1.5% of Spectral Medical shares are held by insiders. Comparatively, 0.8% of Sintx Technologies shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.


Sintx Technologies beats Spectral Medical on 6 of the 10 factors compared between the two stocks.

About Spectral Medical

(Get Free Report)

Spectral Medical Inc., together with its subsidiaries, focuses on the development and commercialization of products for the treatment of septic shock in North America. The company markets Endotoxin Activity Assay, a rapid in vitro diagnostic test for the detection of components of gram negative bacterial cell wall; and Polymyxin B Hemoperfusion, a therapeutic hemoperfusion device that removes endotoxin from the bloodstream. It also develops and manufactures monoclonal and polyclonal antibodies, recombinant cardiac proteins, and calibrators for use in the research and development, as well as products that are manufactured by other diagnostic companies. The company was formerly known as Spectral Diagnostics Inc. and changed its name to Spectral Medical Inc. in December 2014. Spectral Medical Inc. was incorporated in 1991 and is headquartered in Toronto, Canada.

About Sintx Technologies

(Get Free Report)

Sintx Technologies, Inc., an advanced materials company, engages in the research, development, and commercialization of medical devices manufactured with silicon nitride for biomedical, industrial, and antipathogenic applications in the United States. It provides solid and porous silicon nitride; silicon nitrite powder; and silicon nitride coating products, as well as silicon nitride composite materials and polyetherketoneketone. The company was formerly known as Amedica Corporation. Sintx Technologies, Inc. was incorporated in 1996 and is headquartered in Salt Lake City, Utah.

Receive News & Ratings for Spectral Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Spectral Medical and related companies with's FREE daily email newsletter.